Complete Resection of Oligorecurrence of Stage I Lung Adenocarcinoma 19 Years After Operation Dai Sonoda, MD, Masashi Mikubo, MD, Kazu Shiomi, MD, PhD, Yukitoshi Satoh, MD, PhD The Annals of Thoracic Surgery Volume 103, Issue 2, Pages e119-e120 (February 2017) DOI: 10.1016/j.athoracsur.2016.07.023 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Chest computed tomographic scan revealed an abnormal shadow with a clear and smooth border (arrow) in the right chest wall. The Annals of Thoracic Surgery 2017 103, e119-e120DOI: (10.1016/j.athoracsur.2016.07.023) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 (A) Moderately differentiated papillary adenocarcinoma of the right lower lung lobe resected in 1994. (Hematoxylin and eosin; ×200.) (B) Chest wall tumor resected in 2014 showed the same histologic features. (Hematoxylin and eosin, stain, ×200.) The Annals of Thoracic Surgery 2017 103, e119-e120DOI: (10.1016/j.athoracsur.2016.07.023) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Immunochemical staining for thyroid transcription factor (TTF)-1 revealed that both the present chest wall tumor and the previously resected lung cancer were positive for TTF-1 (TTF-1, ×200). The Annals of Thoracic Surgery 2017 103, e119-e120DOI: (10.1016/j.athoracsur.2016.07.023) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions